Patents by Inventor Michel Seve

Michel Seve has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEW BIOMARKERS OF HUMAN SKIN AGING
    Publication number: 20210109111
    Abstract: The present invention refers to an in vitro method to determine if the skin of a subject presents signs of physiological aging, a method of cosmetic and a method to identify a substance that is capable of reducing or reversing the visible signs of physiological skin aging. The invention further refers to a kit comprising capture ligands and a use of said kit for determining in a skin sample the expression level of the markers of skin aging that are identified in context of the present invention.
    Type: Application
    Filed: November 24, 2017
    Publication date: April 15, 2021
    Inventors: Sandrine BOURGOIN-VOILLARD, Sylvia Marie-Louise LEHMANN, Walid RACHIDI, Michel SEVE
  • Antibodies specific for ZNT8
    Patent number: 9568482
    Abstract: Provided are antibodies specific for ZnT8. In particular, provided are monoclonal or polyclonal non-naturally occurring antibodies which specifically recognizes an epitope selected from the group consisting of SEQ ID NO. 7, SEQ ID NO. 8, SEQ ID NO. 9 and SEQ ID NO. 10 as described herein.
    Type: Grant
    Filed: October 19, 2010
    Date of Patent: February 14, 2017
    Assignees: COMMISSARIAT A L'ENERGIE ATOMIQUE, UNIVERSITE JOSEPH FOURIER
    Inventors: Michel Seve, Alain Favier
  • PROTEIN SPECIFIC TO PANCREATIC BETA CELLS IN ISLETS OF LANGERHANS AND APPLICATIONS THEREOF
    Publication number: 20110027807
    Abstract: The invention relates to protein ZnT-8 which is specifically expressed in the pancreatic beta cells in islets of Langerhans, to a polynucleotide encoding said protein which is involved in the maturation and exocytosis of insulin, and to the applications thereof, for example, for sorting and studying beta cells and for screening medicine acting on diabetes and hyperinsulinism.
    Type: Application
    Filed: October 19, 2010
    Publication date: February 3, 2011
    Applicants: COMMISSARIAT A L'ENERGIE ATOMIQUE, UNIVERSITE JOSEPH FOURIER
    Inventors: MICHEL SEVE, ALAIN FAVIER
  • Protein specific to pancreatic beta cells in islets of langerhans and applications thereof
    Patent number: 7851164
    Abstract: The invention relates to protein ZnT-8 which is specifically expressed in the pancreatic beta cells in islets of Langerhans, to a polynucleotide encoding said protein which is involved in the maturation and exocytosis of insulin, and to the applications thereof, for example, for sorting and studying beta cells and for screening medicine acting on diabetes and hyperinsulinism.
    Type: Grant
    Filed: November 18, 2003
    Date of Patent: December 14, 2010
    Assignee: Commissariat a l'Energie Atomique
    Inventors: Michel Seve, Alain Favier
  • Protein specific to pancreatic beta cells in islets of langerhans and applications thereof
    Publication number: 20060246442
    Abstract: The invention relates to protein ZnT-8 which is specifically expressed in the pancreatic beta cells in islets of Langerhans, to a polynucleotide encoding said protein which is involved in the maturation and exocytosis of insulin, and to the applications thereof, for example, for sorting and studying beta cells and for screening medicine acting on diabetes and hyperinsulinism.
    Type: Application
    Filed: November 18, 2003
    Publication date: November 2, 2006
    Inventors: Michel Seve, Alain Favier